Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

NanoNewron LLC
Profile last edited on: 9/16/25      CAGE: -----      UEI: PY1YV7J9FKF3

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
----
First Award
2023
Latest Award
2023
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

80 La Salle Street Apt 20g
New York, NY 10027
   N/A
   N/A
   N/A
Location: Single
Congr. District: 13
County: New York

Public Profile

A biotech company developing a breakthrough approach in Alzheimer’s Disease by targeting TNF-? in the brain, NanoNewron is iindicated as developing humanized camelid nano=bodies for CNS disease

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$499,828
Phase II Dollars
$0
Total Awarded
$499,828

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2023 1 NIH $499,828
Project Title: Discovery of therapeutic nanobodies targeting brain TNF-? for the treatment of Alzheimer Disease

Key People / Management

  Luciano D’adami -- Founder and Chief Scientific Officer

  Luana Fioriti

  Marco Taglietti

Company News

There are no news available.